A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals
about
A Broad RNA Virus Survey Reveals Both miRNA Dependence and Functional SequestrationInterleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replicationMechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapyChikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the BrainA viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge.In Vitro and In Vivo Attenuation of Vesicular Stomatitis Virus (VSV) by Phosphoprotein Deletion.Viral strategies for studying the brain, including a replication-restricted self-amplifying delta-G vesicular stomatis virus that rapidly expresses transgenes in brain and can generate a multicolor golgi-like expressionArs2 regulates both miRNA- and siRNA- dependent silencing and suppresses RNA virus infection in Drosophila.Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus.Nup98 promotes antiviral gene expression to restrict RNA viral infection in DrosophilaAMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis.Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector.Impact of ETIF deletion on safety and immunogenicity of equine herpesvirus type 1-vectored vaccines.Dicer-2 processes diverse viral RNA species.Construction and in vitro evaluation of a recombinant live attenuated PRRSV expressing GM-CSFInduction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus.Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: viral pathogenesis is linked to induction of tumor necrosis factor alphaNonsegmented negative-strand viruses as vaccine vectors.Innate endogenous adjuvants prime to desirable immune responses via mucosal routesNatural resistance-associated macrophage protein is a cellular receptor for sindbis virus in both insect and mammalian hosts.Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.Vesicular stomatitis virus expressing tumor suppressor p53 is a highly attenuated, potent oncolytic agent.Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virus.The transcription factor FoxK participates with Nup98 to regulate antiviral gene expression.A role for granulocyte-macrophage colony-stimulating factor in the regulation of CD8(+) T cell responses to rabies virus.Viral vectored granulocyte-macrophage colony stimulating factor inhibits vaccine protection in an SIV challenge model: protection correlates with neutralizing antibody.Transcriptional pausing controls a rapid antiviral innate immune response in DrosophilaOncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing miceAttenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in miceRecombinant rabies virus expressing dog GM-CSF is an efficacious oral rabies vaccine for dogs.Intranasal co-delivery of IL-6 gene enhances the immunogenicity of anti-caries DNA vaccine.A genome-wide RNAi screen reveals that mRNA decapping restricts bunyaviral replication by limiting the pools of Dcp2-accessible targets for cap-snatchingSingle-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection.Peripheral, but not central nervous system, type I interferon expression in mice in response to intranasal vesicular stomatitis virus infectionA conserved virus-induced cytoplasmic TRAMP-like complex recruits the exosome to target viral RNA for degradation.Intranasal immunization with recombinant vesicular stomatitis virus expressing murine cytomegalovirus glycoprotein B induces humoral and cellular immunity.Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV.Intramuscular immunization with a vesicular stomatitis virus recombinant expressing the influenza hemagglutinin provides post-exposure protection against lethal influenza challenge.Genome-wide RNAi screen identifies SEC61A and VCP as conserved regulators of Sindbis virus entry.
P2860
Q23035986-BD831F9C-FB02-4A7B-937C-0D02BD1E2391Q24651415-D9311C36-837D-4694-ADA9-10AFD8A0D46DQ28083766-FEA84ED5-A1D1-471F-AD4F-E7348D5AEF54Q28223031-1C300E4E-3E89-485B-8DA4-A712FDF36C4AQ30370147-7E79741B-7116-4841-A7C1-DD5608710D63Q30385999-B68BADC7-1849-49C8-BBFA-3CE835E34EF0Q30389455-D1EE2FF3-F3DF-4A16-9A42-0328DF9B3A1FQ30495981-A22B2FA4-C5E8-4982-B850-34BDC573AB05Q33486941-1776C96A-AD7E-491F-B8D4-865317B23065Q33713083-9240CD99-719E-4832-A591-DB0B2D2FF8FDQ34218467-1E473EA3-58A4-42F5-AF79-FDF2D239E36BQ34244912-11C28456-7C90-48A3-8044-D42E6FFAB9A9Q34262131-3E61896A-5852-42C8-A784-AB99B4B0234FQ34296144-B0AFD4C6-FE26-430E-AFA1-35A43828E78AQ34592647-3FE532EF-57CD-456D-BE35-0553698A804EQ34632575-1B73C40F-CBBD-4DAE-8632-EA416231B6D5Q34656877-3BC982E1-A6C7-4BD2-AEA5-699483BD94D1Q34717937-92959BF9-9F0B-4EB2-9F43-DB965E12368BQ35139219-CD39A726-6E2F-4AC2-8168-77FD57C51C0CQ35143128-5729FDF5-02D2-4D45-9BDD-32FFE5D7BE8FQ35188739-E9513216-6712-4EF7-8C76-BC2EA7AF3117Q35232804-7AC6FBDF-1106-4369-AC8E-674669155EB1Q35275179-43BBBADB-C808-40C8-BDC8-802056949C0EQ35575688-526E0AE6-F15B-4BC5-95C8-E8FC20F7E587Q35677583-AF1445D9-DDE3-4B56-93FE-812B05D24C14Q35803316-78C465FB-7C87-4DB7-9C21-D3F3ED6C57F2Q36007614-236A3565-54D1-4818-8407-BF51461BCFCEQ36343296-B94DC3AA-A71A-4250-AE3A-D04C0AA3F00BQ36393363-5593B398-9975-408D-870D-12A5E3E42A38Q36423935-26146AC7-D1EE-487B-8B9F-4AF3FFB59982Q36629350-B074EFB5-D578-4C47-B349-C553BF124073Q36745790-B7411AD5-7EF9-49BA-A0B4-40A296F6734DQ37019225-4B400CAB-F10A-4CE1-B7A7-746C781E7EF1Q37066697-7AFC4208-B903-48BE-81BC-539720824D32Q37076666-5DE942BC-2328-420E-80D8-01E1A4E077B2Q37151378-7E7C46B0-6D40-4AC5-99AA-610461FED4C2Q37243886-BE9EB7C9-C50C-4BBB-9E2B-FEC1B0EE5D0FQ37373616-62F98D90-4404-4FF6-A9F1-9983EE33B0D9Q37455765-9174BB21-1C36-45BF-A859-5D00BBEDBE43Q37576241-BBC5A625-0D0C-4F32-930D-55F07560B337
P2860
A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A vesicular stomatitis virus r ...... ted for replication in animals
@ast
A vesicular stomatitis virus r ...... ted for replication in animals
@en
A vesicular stomatitis virus r ...... ted for replication in animals
@nl
type
label
A vesicular stomatitis virus r ...... ted for replication in animals
@ast
A vesicular stomatitis virus r ...... ted for replication in animals
@en
A vesicular stomatitis virus r ...... ted for replication in animals
@nl
prefLabel
A vesicular stomatitis virus r ...... ted for replication in animals
@ast
A vesicular stomatitis virus r ...... ted for replication in animals
@en
A vesicular stomatitis virus r ...... ted for replication in animals
@nl
P2093
P2860
P1433
P1476
A vesicular stomatitis virus r ...... ted for replication in animals
@en
P2093
Amanda Poholek
Elizabeth Ramsburg
Jean Publicover
John K Rose
Linda Buonocore
Michael Robek
P2860
P304
15043-15053
P356
10.1128/JVI.79.24.15043-15053.2005
P407
P577
2005-12-01T00:00:00Z